Pulmonary toxicity of nanomaterials: A critical comparison of published in vitro assays and in vivo inhalation or instillation studies

Nanomedicine

Volumn 9, Issue 16, 2014, Pages 2557-2585

  Landsiedel, Robert ^a   Sauer, Ursula G ^b   Ma Hock, Lan ^a   Schnekenburger, Jürgen ^c   Wiemann, Martin ^d  

^a BASF SE   (Germany)

^b Animal Welfare Academy   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d Institute for Lung Health (IBE RD GGmbH) Muenster   (Germany)

Author keywords

cytotoxicity; inflammation; intratracheal instillation; metal oxide nanomaterials; multiwalled carbon nanotubes; particle dissolution; short term inhalation study

Indexed keywords

CERIUM OXIDE; METAL NANOPARTICLE; MULTI WALLED NANOTUBE; NANOMATERIAL; SILICON DIOXIDE; SILVER NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE; ZINC OXIDE NANOPARTICLE; CARBON NANOTUBE; CERIC OXIDE; CERIUM; TITANIUM; TITANIUM DIOXIDE; ZINC OXIDE;

BIOLOGICAL ACTIVITY; HUMAN; IN VITRO STUDY; LUNG TOXICITY; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW; ANIMAL; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; LUNG; PATHOLOGY;

ADMINISTRATION, INHALATION; ANIMALS; CERIUM; HUMANS; LUNG; NANOSTRUCTURES; NANOTUBES, CARBON; SILICON DIOXIDE; TITANIUM; ZINC OXIDE;

EID: 84918494721     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.149     Document Type: Review

References (157)

1. Stone V, Johnston H, Schins RPF. Development of in vitro systems for nanotoxicology: methodological considerations. Crit. Rev. Toxicol. 39(7), 613-626 (2009).
2. Kroll A, Dierker C, Rommel C et al. Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays. Part. Fibre Toxicol. 8, 9 (2011).
3. Nel AE, Xia T, Meng H et al. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. Acc. Chem. Res. 46(3), 607-621 (2013).
4. Oberdörster G, Ferin J, Lehnert BE. Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect. 102(Suppl. 5), 173-179 (1994).
5. Nel AE, Nasser E, Godwin H et al. A multi-stakeholder perspective on the use of alternative test strategies for nanomaterial safety assessment. ACS Nano 7(8), 6422-6433 (2013).
6. Cho WS, Duffn R, Bradley M et al. Predictive value of in vitro assays depends on the mechanism of toxicity of metal oxide nanoparticles. Part. Fibre Toxicol. 10(1), 55 (2013).
7. Hirsch C, Roesslein M, Krug HF, Wick P. Nanomaterial cell interactions: are current in vitro tests reliable? Nanomed. 6(5), 837-847 (2011).
8. Wohlleben W, Kolle SN, Hasenkamp LC et al. Artifacts by marker enzyme adsorption on nanomaterials in cytotoxicity assays with tissue cultures. J. Phys. Conf. Series 304, 012061 (2011).
9. Guadagnini R, Halamoda Kenzaoui B, Cartwright L et al. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology doi:10.3109/17435390.829590 (2013) (Epub ahead of print).
10. Xia T, Hamilton R F, Bonner JC et al. Interlaboratory evaluation of in vitro cytotoxicity and infammatory responses to engineered nanomaterials: the NIEHS Nano GO Consortium. Environ. Health Persp. 121(6), 683-690 (2013).
11. Han X, Corson N, Wade-Mercer P et al. Assessing the relevance of in vitro studies in nanotoxicology by examining correlations between in vitro and in vivo data. Toxicology 297(1-3), 1-9 (2012).
12. Sauer UG, Vogel S, Aumann A et al. Applicability of rat precision-cut lung slices in evaluating nanomaterial cytotoxicity, apoptosis, oxidative stress, and infammation. Toxicol. Appl. Pharmacol. 276(1), 1-20 (2014).
13. Rushton EK, Jiang J, Leonard SS et al. Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J. Toxicol. Environ. Health A 73 (5), 445-461 (2010).
14. OECD. Nanosafety at the OECD: The first six years. www.oecd.org/science/nanosafety/
15. Oesch F, Landsiedel R. Genotoxicity investigations on nanomaterials. Arch. Toxicol. 86(7), 985-994 (2012).
16. Russell W, Burch R. The Principles of Humane Experimental Technique. Methuen, York, UK (1959).
17. Hayes A, Bakand S. Inhalation toxicology. EXS 100, 461-488 (2010).
18. Landsiedel R, Fabian E, Ma-Hock L et al. Toxico-/biokinetics of nanomaterials. Arch. Toxicol. 86 (7), 1021-1060 (2012).
19. Savolainen K, Backman U, Brouwer D et al. Nanosafety in Europe 2015-20125: towards safe and sustainable nanomaterials and nanotechnology innovations. www.ttl.f/en/publications/electronic-publications
20. ICRP (International Commission on Radiological Protection). Human respiratory tract model for radiological protection. Ann. ICRP 24(1-3), 231 (1994).
21. Bräu M, Ma-Hock L, Hesse C et al. Nanostructured calcium silicate hydrate seeds accelerate concrete hardening, a combined assessment of benefts and risks. Arch. Toxicol. 86(7), 1077-1087 (2012).
22. Anttila S. Dissolution of stainless steel welding fumes in the rat lung: an x ray microanalytical study. Br. J. Ind. Med. 43(9), 592-596 (1986).
23. Morrow PE. Possible mechanisms to explain dust overloading of the lungs. Fund. Appl. Toxicol. 10(3), 369-384 (1988).
24. Donaldson K, Tran L. Infammation caused by particles and fbers. Inhal. Toxicol. 14(1), 5-27 (2002).
25. Monteiller C, Tran L, MacNee W et al. The pro-infammatory effects of low-toxicity low-solubility particles, nanoparticles and fne particles, on epithelial cells in vitro: the role of surface area. Occup. Environ. Med. 64(9), 609-615 (2007).
26. Pauluhn J. Comparative pulmonary response to inhaled nanostructures: considerations on test design and endpoints. Inhal. Toxicol. 21(Suppl. 1), 40-54 (2009).
27. European Centre for Exotoxicology and Toxicology of Chemicals. Technical Report 122. Poorly soluble particles. Lung overload. www.ecetoc.org
28. Oomen AG, Bos PMJ, Fernandes TF et al. Concern-driven integrated approaches to nanomaterial testing and assessment-Report of the NanoSafety Cluster Working Group 10. Nanotoxicology 8(3), 334-348 (2014).
29. Donaldson K, Poland CA. Nanotoxicity: challenging the myth of nano-specifc toxicity. Curr. Opin. Biotechnol. 24(4), 724-734 (2013).
30. 2+ dissolution inside lysosomes. Part. Fibre Toxicol. 8, 27 (2011).
31. Cho WS, Duffn R, Poland CA et al. Differential pro-infammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology 6(1), 22-35 (2012).
32. Nel AE, Mädler L, Velegol D et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8(7), 543-557 (2009).
33. Wang A, Berg EL, Polokoff M et al. Ranking and profling nanomaterial (NM) bioactivity by ToxCast high-throughput screening (HTS). Presented at: 52nd Annual Meeting of the Soc Toxicol (SOT). San Antonio, TX, USA, 10-14 March 2013.
34. Landsiedel R, Wiench K, Wohlleben W. Geeignete Methoden zur Prüfung der Sicherheit von Nanomaterialien. Chemie Ingenieur Technik 80, 1641-1651 (2008).
35. Landsiedel R, Ma-Hock L, Kroll A et al. Testing metal-oxide nanomaterials for human safety. Adv. Mater. 22(24), 2601-2627 (2010).
36. Shvedova AA, Yanamala N, Murray AR et al. Oxidative stress, infammatory biomarkers, and toxicity in mouse lung and liver after inhalation exposure to 100% biodiesel or petroleum diesel emissions. J. Toxicol. Environ. Health A 76(15), 907-921 (2013).
37. Shvedova AA, Pietroiusti A, Fadeel B, Kagan VE. Mechanisms of carbon nanotube-induced toxicity: focus on oxidative stress. Toxicol. Appl. Pharmacol. 261(2), 121-133 (2012).
38. Yanamala N, Kagan VE, Shvedova AA. Molecluar modeling in structural nano-toxicology: interactions of nano-particles with nano-machinery of cells. Adv. Drug Deliv. Rev. 65 (15), 2070-2077 (2013).
39. Kreyling WG, Semmler M, Erbe F et al. Translocation of ultrafne insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J. Toxicol. Environ. Health A 65(20), 1513-1530 (2002).
40. Kreyling WG, Semmler-Behnke M, Seitz J et al. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal. Toxicol. 21(Suppl. 1), 55-60 (2009).
41. Maier M, Hannebauer B, Holldorff H, Albers P. Does lung surfactant promote disaggregation of nanostructured titanium dioxide? J. Occup. Environ. Med. 48(12), 1314-1320 (2006).
42. 2 inhalation exposures. Nanotoxicology 7(8), 1338-1350 (2013).
43. Cohen JM, Teeguarden JG, Demokritou P. An integrated approach for the in vitro dosimetry of engineered nanomaterials. Part. Fibre Toxicol. 11, 20 (2014).
44. Lundqvist M, Stigler J, Cedervall T et al. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 5(9), 7503-7509 (2011).
45. Monopoli MP, Walczyk D, Campbell A et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 133(8), 2525-2534 (2011).
46. Monopoli MP, Åberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 7(12), 779-786 (2012).
47. Wolfram J, Yang Y, Shen J et al. The nano-plasma interface: implications of the protein corona. Colloids Surf. B Biointerfaces doi 10.1016j.colsurfb.02.035 (2014) (Epub ahead of print).
48. Bihari P, Vippola M, Schultes S et al. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part. Fibre Toxicol. 5, 14 (2008).
49. Sauer UG, Aumann A, Ma-Hock L, Landsiedel R, Wohlleben W. Infuence of dispersive agent on nanomaterial agglomeration and implications for biological effects in vivo or in vitro. Toxicol. In Vitro 29, 182-186 (2014).
50. Hu G, Jiao B, Shi X, Valle RP, Fan Q, Zuo YY. Physicochemical properties of nanoparticles regulate translocation across pulmonary surfactant monolayer and formation of lipoprotein corona. ACS Nano 7(12), 10525-10533 (2013).
51. Choi HS, Ashitate Y, Lee JH et al. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat. Biotechnol. 28(12), 1300-1303 (2010).
52. Landsiedel R, Ma-Hock L, Haussmann HJ, van Ravenzwaay B, Kayser M, Wiench K. Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4(4), 399-413 (2012).
53. Pauluhn J. Common denominators of carbon nanotubes. In: Nanomaterials. Commission for the Investigation of Health Hazards of Chemical Compounds. Report. Deutsche Forschungsgemeinschaft (Ed.). Wiley-VCH Verlag GmbH, Weinheim, Germany, 68-83 (2013).
54. Schulze C, Kroll A, Lehr C et al. Not ready to use-overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology 2, 51-61 (2008).
55. Oberdörster G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J. Int. Med. 267(1), 89-105 (2009).
56. Heng BC, Zhao X, Xiong S, Ng KW, Boey FYC, Loo JSC. Cytotoxicity of zinc oxide (ZnO) nanoparticles is infuenced by cell density and culture format. Arch. Toxicol. 85(6), 695-704 (2011).
57. Braakhuis HM, Park MV, Gosens I, De Jong WH, Cassee FR. Physicochemical characteristics of nanomaterials that affect pulmonary infammation. Part. Fibre Toxicol. 11, 18 (2014).
58. Duffn R, Tran L, Brown D, Stone V, Donaldson K. Proinfammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal. Toxicol. 19(10), 849-856 (2007).
59. Tran CL, Buchanan D, Cullen RT, Searl A, Jones AD, Donaldson K. Inhalation of poorly soluble particles. II. Infuence of particle surface area on infammation and clearance. Inhal. Toxicol. 12 (12), 1113-1126 (2000).
60. Kuempel ED, Castranova V, Geraci CL, Schulte PA. Development of risk-based nanomaterial groups for occupational exposure control. J. Nanopart. Res. 14, 1029 (2012).
61. Pauluhn J. Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fbrillar structures. Toxicol. Sci. 113(1), 226-242 (2010).
62. Wiemann M, Bruch J. Comparison of in vitro and in vivo fndings. In: NanoCare. Health related Aspects of Nanomaterials. Final Scientifc Report. Kuhlbusch TKJ, Nau K, Krug H (Eds). Dechema, Frankfurt, Germany, 68-73 (2009).
63. Gosens I, Post JA, de la Fonteyne LJJ et al. Impact of agglomeration state of nano-and submicron sized gold particles on pulmonary infammation. Part. Fibre Toxicol. 7(1), 37 (2010).
64. Donaldson K, Borm PJ, Oberdörster G, Pinkerton KE, Stone V, Tran CL. Concordance between in vitro and in vivo dosimetry in the proinfammatory effects of low-toxicity, low-solubility particles: the key role of the proximal alveolar region. Inhal. Toxicol. 20(1), 53-62 (2008).
65. Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, Pounds JG. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol. Sci. 95(2), 300-312 (2007).
66. Hinderliter PM, Minard KR, Orr G et al. ISDD: acomputational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part. Fibre Toxicol. 7(1), 36 (2010).
67. Anjilvel S, Asgharian B. A multiple-path model of particle deposition in the rat lung. Fundam. Appl. Toxicol. 28(1), 41-50 (1995).
68. Schippritt D, Lipinski HG, Wiemann M. Measurement of nanoparticle uptake by alveolar macrophages: a new approach based on quantitative image analysis. In: Nanomaterials Throughout their Lifecycles: Safety, Human Hazard and Exposure. Wohlleben W, Kuhlbusch T, Schnekenburger J, Lehr C-M (Eds). Taylor & Francis, FL, USA (2014).
69. Simko M, Nosske D, Kreyling WG. Metrics, dose, and dose concept: the need for a proper dose concept in the risk assessment of nanoparticles. Int. J. Environ. Res. Public Health 11(4), 4026-4048 (2014).
70. Meng H, Xia T, George S, Nel AE. A predictive toxicological paradigm for the safety assessment of nanomaterials. ACS Nano 3(7), 1620-1627 (2009).
71. Damoiseaux R, George S, Li M et al. No time to lose-high throughput screening to assess nanomaterial safety. Nanoscale 3(4), 1345-1360 (2011).
72. Yu KN, Yoon TJ, Minai-Tehrani A et al. Zinc oxide nanoparticle induced autophagic cell death and mitochondrial damage via reactive oxygen species generation. Toxicol. In Vitro 27 (4), 1187-1195 (2013).
73. Johnston HJ, Hutchison GR, Christensen FM, Peters S, Hankin S, Stone V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit. Rev. Toxicol. 40(4), 328-346 (2010).
74. Kermanizadeh A, Pojana G, Gaiser BK et al. In vitro assessment of engineered nanomaterials using a hepatocyte cell line: cytotoxicity, pro-infammatory cytokines and functional markers. Nanotoxicology 7(3), 301-313 (2013).
75. Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI. Induction of infammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ. Health Perspect. 115 (3), 403-409 (2007).
76. Hackenberg S, Scherzed A, Technau A et al. Cytotoxic, genotoxic and pro-infammatory effects of zinc oxide nanoparticles in human nasal mucosa cells in vitro. Toxicol. In Vitro 25(3), 657-663 (2011).
77. 2 nanoparticles toward human lung epithelial cells. Sci. Total Environ. 409(7), 1219-1228 (2011).
78. Palomäki J, Karisola P, Pylkkänen L, Savolainen K, Alenius H. Engineered nanomaterials cause cytotoxicity and activation on mouse antigen presenting cells. Toxicology 267(1-3), 125-131 (2010).
79. Roy R, Tripathi A, Das M, Dwivedi PD. Cytotoxicity and uptake of zinc oxide nanoparticles leading to enhanced infammatory cytokines levels in murine macrophages: comparison with bulk zinc oxide. J. Biomed. Nanotechnol. 7(1), 110-111 (2011).
80. Park EJ, Yi J, Chung KH, Ryu DY, Choi J, Park K. Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicol. Lett. 180(3), 222-229 (2008).
81. Feltis BN, O'Keefe SJ, Harford AJ, Piva TJ, Turney TW, Wright PFA. Independent cytotoxic and infammatory responses to zinc oxide nanoparticles in human monocytes and macrophages. Nanotoxicology 6(7), 757-765 (2012).
82. Foldbjerg R, Dang DA, Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch. Toxicol. 85(7), 743-750 (2011).
83. Heng BC, Zhao X, Tan EC et al. Evaluation of the cytotoxic and infammatory potential of differentially shaped zinc oxide nanoparticles. Arch. Toxicol. 85(12), 1517-1528 (2011).
84. Herzog F, Clift MJD, Piccapietra F et al. Exposure of silver-nanoparticles and silver ions to lung cells in vitro at the air liquid interface. Part. Fibre Toxicol. 10, 11 (2013).
85. Kim HR, Kim MJ, Lee SY, Oh SM, Chung KH. Genotoxic effects of silver nanoparticles stimulated by oxidative stress in human normal bronchial epithelial (BEAS-2B) cells. Mutat. Res. 726(2), 129-135 (2011).
86. Roy R, Parashar V, Chauhan LK et al. Mechanism of uptake of ZnO nanoparticles and infammatory responses in macrophages require PI3K mediated MAPKs signaling. Toxicol. In Vitro 28, 457-467 (2013).
87. Sayes CM, Reed KL, Warheit DB. Assessing toxicity of fne and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profles. Toxicol. Sci. 97(1), 163-180 (2007).
88. Landsiedel R, Ma-Hock L, Hofmann T et al. Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials. Part. Fibre Toxicol. 11, 16 (2014).
89. Sung JH, Ji JH, Song KS et al. Acute inhalation toxicity of silver nanoparticles. Toxicol. Ind. Health 27(2), 149-154 (2011).
90. Sung JH, Ji JH, Park JD et al. Subchronic inhalation toxicity of silver nanoparticles. Toxicol. Sci. 108(2), 452-461 (2009).
91. Song KS, Sung JH, Ji JH et al. Recovery from silver-nanoparticle-exposure-induced lung infammation and lung function changes in Sprague Dawley rats. Nanotoxicology 7(2), 169-180 (2013).
92. Joint Research Centre. Institute for Health and Consumer Protection (IHCP). List of materials in the JRC nanomaterials repository-Oct 2011. http://ihcp.jrc.ec.europa.eu/our-activities/nanotechnology/
93. Wilkinson LJ, White RJ, Chipman JK. Silver and nanoparticles of silver in wound dressings: a review of effcacy and safety. J. Wound Care 20(11), 543-549 (2011).
94. Kao YY, Chen YC, Cheng TJ, Chiung YM, Liu PS. Zinc oxide nanoparticles interfere with zinc ion homeostasis to cause cytotoxicity. Toxicol. Sci. 125(2), 462-472 (2012).
95. Klein CL, Wiench K, Wiemann M, Ma-Hock L, van Ravenzwaay B, Landsiedel R. Hazard identifcation of inhaled nanomaterials: making use of short-term inhalation studies. Arch. Toxicol. 86(7), 1137-1151 (2012).
96. Guadagnini R, Moreau K, Hussain S, Marano F, Boland S. Toxicity evaluation of engineered nanoparticles for medical applications using pulmonary epithelial cells. Nanotoxicology doi:10.3109/17435390.855830 (2013) (Epub ahead of print).
97. 3 nanoparticles-induced toxic effects on human fetal lung fbroblasts. Biomed. Environ. Sci. 24(6), 661-669 (2011).
98. Bermudez E, Mangum JB, Asgharian B et al. Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of micron-scale titanium dioxide particles. Toxicol. Sci. 70(1), 86-97 (2002).
99. Bermudez E, Mangum JB, Wong BA et al. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafne titanium dioxide particles. Toxicol. Sci. 77(2), 347-357 (2004).
100. Heinrich U, Fuhst R, Rittinghausen S et al. Chronic inhalation exposure of Wistar rats and two different strains of mice to diesel engine exhaust, carbon black, and titanium dioxide. Inhal. Toxicol. 7, 533-556 (1995).
101. 2) by inhalation for two years. Toxicol. Appl. Pharmacol. 79(2), 179-192 (1985).
102. Ma-Hock L, Burkhardt S, Strauss V et al. Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance. Inhal. Toxicol. 21(2), 102-118 (2009).
103. Pott F, Roller M. Carcinogenicity study with nineteen granular dusts in rats. Eur. J. Oncol. 10, 249-281 (2005).
104. 2 and quartz. Toxicol. Lett. 186 (3), 152-159 (2009).
105. Sayes CM, Wahi R, Kurian PA et al. Correlating nanoscale titania structure with toxicity: a cytotoxicity and infammatory response study with human dermal fbroblasts and human lung epithelial cells. Toxicol. Sci. 92(1), 174-185 (2006).
106. 2 particulates: the contribution of physicochemical characteristics. Part. Fibre Toxicol. 6, 33 (2009).
107. Ferin J, Oberdörster G, Penney DP. Pulmonary retention of ultrafne and fne particles in rats. Am. J. Respir. Cell Mol. Biol. 6(5), 535-542 (1992).
108. Park EJ, Choi J, Park YK, Park K. Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology 245(1-2), 90-100 (2008).
109. 2 nanoparticles via p38-Nrf-2 signaling pathway in human bronchial epithelial cell, Beas-2B. Toxicol. Lett. 187(2), 77-83 (2009).
110. 2 and ZnO nanoparticles to human lung cells. J. Nanosci. Nanotechnol. 10 (5), 3453-3458 (2010).
111. Shi J, Karlsson HL, Johansson K et al. Microsomal glutathione transferase 1 protects against toxicity induced by silica nanoparticles but not by zinc oxide nanoparticles. ACS Nano 6 (3), 1925-1938 (2012).
112. De Marzi L, Monaco A, De Lapuente J et al. Cytotoxicity and genotoxicity of ceria nanoparticles on different cell lines in vitro. Int. J. Mol. Sci. 14(2), 3065-3077 (2013).
113. Schubert D, Dargusch R, Raitano J, Chan SW. Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem. Biophys. Res. Commun. 342(1), 386 (2006).
114. Xia T, Kovochich M, Liong M et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2 (10), 2121-2134 (2008).
115. Cho WS, Duffn R, Poland CA et al. Metal oxide nanoparticles induce unique infammatory footprints in the lung: important implications for nanoparticle testing. Environ. Health Perspect. 118(12), 1699-1706 (2010).
116. Srinivas A, Rao PJ, Selvam G, Murthy PB, Reddy PN. Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicol. Lett. 205(2), 105-115 (2011).
117. Arts JH, Muijser H, Duistermaat E et al. Five-day inhalation toxicity study of three types of synthetic amorphous silicas in Wistar rats and post-exposure evaluations for up to 3 months. Food Chem. Toxicol. 45 (10), 1856-1867 (2007).
118. Napierska D, Thomassen LC, Lison D, Martens JA, Hoet PH. The nanosilica hazard: another variable entity. Part. Fibre Toxicol. 7(1), 39 (2010).
119. 2 nanoparticles as a function of particle size. Environ. Sci. Technol. 46(9), 4909-4915 (2012).
120. Horie M, Nishio K, Kato H et al. Evaluation of cellular effects of silicon dioxide nanoparticles. Toxicol. Mech. Methods 24(3), 196-203 (2014).
121. Ha SW, Sikorski JA, Weitzmann MN, Beck GR Jr. Bio-active engineered 50nm silica nanoparticles with bone anabolic activity: therapeutic index, effective concentration, and cytotoxicity profle in vitro. Toxicol. In Vitro 28, 354-364 (2013).
122. Uboldi C, Giudetti G, Broggi F, Gilliland D, Ponti J, Rossi F. Amorphous silica nanoparticles do not induce cytotoxicity, cell transformation or genotoxicity in Balb/3T3 mouse fbroblasts. Mutat. Res. 745(1-2), 11-20 (2012).
123. Kasper J, Hermanns MI, Bantz C et al. Interactions of silica nanoparticles with lung epithelial cells and the association to fotillins. Arch. Toxicol. 87(6), 1053-1065 (2013).
124. Napierska D, Thomassen LC, Rabolli V et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 5(7), 846-853 (2009).
125. Coccini T, Manzo L, Roda E. Safety evaluation of engineered nanomaterials for health risk assessment: an experimental tiered testing approach using pristine and functionalized carbon nanotubes. ISRN Toxicol. 2013, 825427 (2013).
126. Panas A, Marquardt C, Nalcaci O et al. Screening of different metal oxide nanoparticles reveals selective toxicity and infammatory potential of silica nanoparticles in lung epithelial cells and macrophages. Nanotoxicology 7(3), 259-273 (2013).
127. Wilhelmi V, Fischer U, van Berlo D, Schulze-Osthoff K, Schins RPF, Albrecht C. Evaluation of apoptosis induced by nanoparticles and fne particles in R AW 264.7 macrophages: facts and artefacts. Toxicol. In Vitro 26(2), 323-334 (2012).
128. Zhu M, Nie G, Meng H, Xia T, Nel AE, Zhao Y. Physicochemical properties determine nanomaterial cellular uptake, transport and fate. Acc. Chem. Res. 46(3), 622-631 (2013).
129. Johnston CJ, Driscoll KE, Finkelstein JN et al. Pulmonary chemokine and mutagenic responses in rats after subchronic inhalation of amorphous and crystalline silica. Toxicol. Sci. 56(2), 405-413 (2000).
130. Reuzel PG, Bruijntjes J P, Feron VJ, Woutersen RA. Subchronic inhalation toxicity of amorphous silicas and quartz dust in rats. Food Chem. Toxicol. 29(5), 341-354 (1991).
131. Chusuei CC, Wu CH, Mallavarapu S et al. Cytotoxicity in the age of nano: the role of fourth period transition metal oxide nanoparticle physicochemical properties. Chem. Biol. Interact. 206(2), 319-326 (2013).
132. Burello E, Worth AP. A theoretical framework for predicting the oxidative stress potential of oxide nanoparticles. Nanotoxicology 5(2), 228-235 (2011).
133. Johnston HJ, Hutchison GR, Christensen FM et al. A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: the contribution of physico-chemical characteristics. Nanotoxicology 4(2), 207-246 (2010).
134. Schinwald A, Donaldson K. Use of back-scatter electron signals to visualize cell/nanowires interactions in vitro and in vivo; frustrated phagocytosis of long fbres in macrophages and compartmentalisation in mesothelial cells in vivo. Part. Fibre Toxicol. 9, 34 (2012).
135. Rodriguez-Yanez Y, Munoz B, Albores A. Mechanisms of toxicity by carbon nanotubes. Toxicol. Mech. Meth. 23(3), 178-195 (2013).
136. Donaldson K, Murphy FA, Duffn R, Poland CA. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fbre retention in the parietal pleura, infammation and mesothelioma. Part. Fibre Toxicol. 22, 5 (2010).
137. Schinwald A, Murphy FA, Prina-Mello A et al. The threshold length for fber-induced acute pleural infammation: shedding light on the early events in asbestos-induced mesothelioma. Toxicol. Sci. 128(2), 461-470 (2012).
138. Schinwald A, Chernova T, Donaldson K. Use of silver nanowires to determine thresholds for fbre length-dependent pulmonary infammation and inhibition of macrophage migration in vitro. Part. Fibre Toxicol. 9, 47 (2012).
139. Murphy FA, Schinwald A, Poland CA, Donaldson K. The mechanism of pleural infammation by long carbon nanotubes: interaction of long fbres with macrophages stimulates them to amplify pro-infammatory responses in mesothelial cells. Part. Fibre Toxicol. 9, 8 (2012).
140. Chen B, Liu Y, Song WM, Hayashi Y, Ding XC, Li WH. In vitro evaluation of cytotoxicity and oxidative stress induced by multiwalled carbon nanotubes in murine R AW 264.7 macrophages and human A549 lung cells. Biomed. Environ. Sci. 24 (6), 593-601 (2011).
141. Cavallo D, Fanizza C, Ursini CL et al. Multi-walled carbon nanotubes induce cytotoxicity and genotoxicity in human lung epithelial cells. J. Appl. Toxicol. 32(6), 454-464 (2012).
142. Haniu H, Saito N, Matsuda Y et al. Effect of dispersants of multi-walled carbon nanotubes on cellular uptake and biological responses. Int. J. Nanomed. 6, 3295-3307 (2011).
143. Aldieri E, Fenoglio I, Cesano F et al. The role of iron impurities in the toxic effects exerted by short multiwalled carbon nanotubes (MWCNT) in murine alveolar macrophages. J. Toxicol. Env. Health Part A 76 (18), 1056-1071 (2013).
144. Ursini CL, Cavallo D, Fresegna AM et al. Comparative cyto-genotoxicity assessment of functionalized and pristine multiwalled carbon nanotubes on human lung epithelial cells. Toxicol. In Vitro 26(6), 831-840 (2012).
145. Ma-Hock L, Strauss V, Treumann S et al. Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black. Part. Fibre Toxicol. 10, 23 (2013).
146. Ma-Hock L, Treumann S, Strauss V et al. Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months. Toxicol. Sci. 112(2), 468-481 (2009).
147. Ge C, Li Y, Yin JJ et al. The contributions of metal impurities and tube structure to the toxicity of carbon nanotube materials. NPG Asia Materials 4, e32 (2012).
148. Sargent LM, Porter DW, Staska LM et al. Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes. Part. Fibre Toxicol. 11, 3 (2014).
149. Shvedova AA, Tkach AV, Kisin ER et al. Carbon nanotubes enhance metastatic growth of lung carcinoma via up-regulation of myeloid-derived suppressor cells. Small 9 (9-10), 1691-1695 (2013).
150. Muller J, Delos M, Panin N, Rabolli V, Huaux F, Lison D. Absence of carcinogenic response to multiwall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat. Toxicol Sci. 110(2), 442-448 (2009).
151. Joris F, Manshian BB, Peynshaert K, De Smedt SC, Braeckmans K, Soenen SJ. Assessing nanoparticle toxicity in cell-based assays: infuence of cell culture parameters and optimized models for bridging the in vitro-in vivo gap. Chem. Soc. Rev. 42(21), 8339-8359 (2013).
152. Balls M, Fentem J. The use of basal cytotoxicity and target organ tests in hazard identifcation and risk assessment. ATLA 20, 368-388 (1992).
153. European Chemicals Agency. Guidance on information requirements and chemical safety assessment. Appendix R7-1 Recommendations for nanomaterials applicable to Chapter R7a Endpoint specifc guidance (2012). http://echa.europa.eu/documents/10162/13632/appendix- r7a-nanomaterials-en.pdf
154. European Chemicals Agency. Assessing human health and environmental hazards of nanomaterials-best practice for REACH registrants. 2nd GAARN meeting. European Chemicals Agency, Helsinki, 21-22 January 2013. http://echa.europa.eu/documents/10162/5399565/best- practices-human-health-environment-nano-en.pdf
155. Sauer UG. Conference Report. Session Nanotoxicology. 16th Congress on Alternatives to Animal Testing. Linz 2010. ALTEX 27, 318-322 (2010).
156. Patel T, Telesca D, Low-Kam C et al. Relating nanoparticle properties to biological outcomes in exposure escalation experiments. Environmetrics 25(1), 57-68 (2014).
157. Lai DY. Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4(1), 1-15 (2012).